1. Home
  2. HCAT vs OABI Comparison

HCAT vs OABI Comparison

Compare HCAT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • OABI
  • Stock Information
  • Founded
  • HCAT 2008
  • OABI 2012
  • Country
  • HCAT United States
  • OABI United States
  • Employees
  • HCAT N/A
  • OABI N/A
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • OABI Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCAT Technology
  • OABI Health Care
  • Exchange
  • HCAT Nasdaq
  • OABI Nasdaq
  • Market Cap
  • HCAT 238.6M
  • OABI 230.3M
  • IPO Year
  • HCAT 2019
  • OABI N/A
  • Fundamental
  • Price
  • HCAT $3.36
  • OABI $1.62
  • Analyst Decision
  • HCAT Hold
  • OABI Strong Buy
  • Analyst Count
  • HCAT 11
  • OABI 3
  • Target Price
  • HCAT $4.70
  • OABI $6.67
  • AVG Volume (30 Days)
  • HCAT 1.2M
  • OABI 386.6K
  • Earning Date
  • HCAT 11-05-2025
  • OABI 08-06-2025
  • Dividend Yield
  • HCAT N/A
  • OABI N/A
  • EPS Growth
  • HCAT N/A
  • OABI N/A
  • EPS
  • HCAT N/A
  • OABI N/A
  • Revenue
  • HCAT $316,093,000.00
  • OABI $23,027,000.00
  • Revenue This Year
  • HCAT $5.57
  • OABI N/A
  • Revenue Next Year
  • HCAT $2.32
  • OABI $44.99
  • P/E Ratio
  • HCAT N/A
  • OABI N/A
  • Revenue Growth
  • HCAT 5.55
  • OABI 6.05
  • 52 Week Low
  • HCAT $2.52
  • OABI $1.22
  • 52 Week High
  • HCAT $9.24
  • OABI $4.87
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 49.24
  • OABI 40.14
  • Support Level
  • HCAT $3.13
  • OABI $1.51
  • Resistance Level
  • HCAT $3.42
  • OABI $1.73
  • Average True Range (ATR)
  • HCAT 0.20
  • OABI 0.12
  • MACD
  • HCAT 0.03
  • OABI -0.01
  • Stochastic Oscillator
  • HCAT 53.23
  • OABI 18.54

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: